Looking for long-term growth in healthcare and beyond

Investors looking for long-term healthcare opportunities are increasingly focused on solutions that combine new technologies with personalization. One recent development was the 26 April headline announcing that the first UK patients will begin a phase 3 trial of a personalized mRNA cancer treatment, known as mRNA-4157 (V940), at University College…